Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.

Hasnain M, Vieweg WV, Hollett B.

Postgrad Med. 2012 Jul;124(4):154-67. doi: 10.3810/pgm.2012.07.2577. Review.

PMID:
22913904
2.
3.

Weight considerations in psychotropic drug prescribing and switching.

Hasnain M, Vieweg WV.

Postgrad Med. 2013 Sep;125(5):117-29. doi: 10.3810/pgm.2013.09.2706. Review.

PMID:
24113670
4.

Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.

Maayan L, Correll CU.

J Child Adolesc Psychopharmacol. 2011 Dec;21(6):517-35. doi: 10.1089/cap.2011.0015. Epub 2011 Dec 13. Review.

PMID:
22166172
5.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients..

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

6.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
7.

Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.

Baptista T, Kin NM, Beaulieu S, de Baptista EA.

Pharmacopsychiatry. 2002 Nov;35(6):205-19. Review.

PMID:
12518268
8.

Interactions between antiepileptics and second-generation antipsychotics.

de Leon J, Santoro V, D'Arrigo C, Spina E.

Expert Opin Drug Metab Toxicol. 2012 Mar;8(3):311-34. doi: 10.1517/17425255.2012.660918. Epub 2012 Feb 15. Review.

PMID:
22332980
9.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly..

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
10.

Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs.

Hasnain M, Fredrickson SK, Vieweg WV.

J Psychopharmacol. 2011 Jun;25(6):715-21. doi: 10.1177/0269881110389214. Epub 2010 Dec 17. Review.

PMID:
21169390
11.

Weight gain and antipsychotics: a drug safety review.

Musil R, Obermeier M, Russ P, Hamerle M.

Expert Opin Drug Saf. 2015 Jan;14(1):73-96. doi: 10.1517/14740338.2015.974549. Epub 2014 Nov 15. Review.

PMID:
25400109
12.

[Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].

Ruetsch O, Viala A, Bardou H, Martin P, Vacheron MN.

Encephale. 2005 Jul-Aug;31(4 Pt 1):507-16. Review. French.

PMID:
16389718
13.
14.

Off-label second generation antipsychotics for impulse regulation disorders: a review.

Scheltema Beduin A, de Haan L.

Psychopharmacol Bull. 2010;43(3):45-81. Review.

PMID:
21150846
15.

A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults.

Citrome L, Kalsekar I, Baker RA, Hebden T.

Curr Med Res Opin. 2014 Aug;30(8):1629-41. doi: 10.1185/03007995.2014.908280. Epub 2014 May 19. Review.

PMID:
24666104
16.

Clinically relevant interactions between newer antidepressants and second-generation antipsychotics.

Spina E, de Leon J.

Expert Opin Drug Metab Toxicol. 2014 May;10(5):721-46. doi: 10.1517/17425255.2014.885504. Epub 2014 Feb 5. Review.

PMID:
24494611
17.

Influence of the drug exposure definition on the assessment of the antipsychotic metabolic impact in patients initially treated with mood-stabilizers.

Tournier M, Bégaud B, Cougnard A, Auleley GR, Deligne J, Blum-Boisgard C, Thiébaut AC, Verdoux H.

Br J Clin Pharmacol. 2012 Jul;74(1):189-96. doi: 10.1111/j.1365-2125.2012.04184.x.

18.

Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.

Ellinger LK, Ipema HJ, Stachnik JM.

Ann Pharmacother. 2010 Apr;44(4):668-79. doi: 10.1345/aph.1M550. Epub 2010 Mar 16. Review.

PMID:
20233913
19.

Effects of six second generation antipsychotics on body weight and metabolism - risk assessment and results from a prospective study.

Tschoner A, Engl J, Rettenbacher M, Edlinger M, Kaser S, Tatarczyk T, Effenberger M, Patsch JR, Fleischhacker WW, Ebenbichler CF.

Pharmacopsychiatry. 2009 Jan;42(1):29-34. doi: 10.1055/s-0028-1100425. Epub 2009 Jan 19.

PMID:
19153944
20.

Weight gain in Asian patients on second-generation antipsychotics.

Mahendran R, Hendricks M, Chan YH.

Ann Acad Med Singapore. 2010 Feb;39(2):118-21.

Supplemental Content

Support Center